Workflow
Moleculin Announces Positive Results from Phase 1 Clinical Trial Evaluating WP1066 for the Treatment of Pediatric Recurrent Malignant Brain Tumors
Globenewswire· 2025-12-17 13:31
Emory University physician-sponsored clinical trial conducted at the Aflac Cancer and Blood Disorders Center at Children’s Healthcare of AtlantaResults demonstrated WP1066 induces anti-tumor immune responses and were recently published in the Journal of Clinical Investigation Insight WP1066 found to be safe and effective, warranting a Phase 2 trial HOUSTON, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced positive results from the Emor ...
Renewal Fuels, Inc. Announces Execution of Transformative Merger with Kepler Fusion Technologies
Prism Media Wire· 2025-12-17 13:30
Core Insights - Renewal Fuels, Inc. has announced a definitive merger with Kepler Fusion Technologies, marking a strategic shift towards advanced energy infrastructure focused on fusion technology [4][8][9] - The merger will result in Kepler becoming a wholly owned subsidiary of Renewal Fuels, with equity holders of Kepler receiving common stock of Renewal Fuels [5][6] - The company plans to rebrand as "American Fusion" to align its identity with its new focus on fusion energy technologies [6][8] Company Transition - The merger represents a fundamental reset for Renewal Fuels, transitioning from its previous business model to a fusion-centric platform [8][9] - Kepler's Texatron platform is designed for continuous, zero-emission baseload electricity, targeting industrial, commercial, and defense applications [7][8] - The combined company aims to pursue scalable deployment opportunities and long-term value creation through a defined commercialization strategy [8][9] Financial and Operational Strategy - The company anticipates a valuation exceeding $300 million following a third-party valuation of Kepler's intellectual property and operating assets [10] - Renewal Fuels is engaging a PCAOB registered audit firm to enhance financial reporting standards and support future capital market initiatives [11] - The company is also exploring uplisting strategies to expand institutional market access post-merger [11] Legal Matters - Renewal Fuels is involved in litigation regarding the return and cancellation of approximately 1,683,000,000 previously issued shares, representing about 59% of its outstanding common stock [12][13] - The company intends to seek court relief to effect the return and cancellation of these shares, which are currently restricted and not eligible for resale [12][13]
Alphabet: From AI Victim To AI King
Seeking Alpha· 2025-12-17 13:30
Core Insights - The article discusses the author's previous positive rating on Alphabet (GOOG/GOOGL) and highlights a focus on undervalued companies with strong fundamentals and cash flows [1] Group 1: Investment Focus - The company emphasizes a long-term value investing approach, particularly in sectors like Oil & Gas and consumer goods, which are often overlooked [1] - Energy Transfer is identified as a company that has been undervalued and is now considered a strong investment opportunity [1] Group 2: Investment Strategy - The author expresses a preference for understanding traditional businesses over high-tech or certain consumer goods, indicating a selective investment strategy [1] - There is a mention of interest in deal arbitrage opportunities, citing examples like Microsoft/Activision Blizzard and Spirit Airlines/Jetblue [1]
Morien Announces Closing of $1.6 Million Non-Brokered LIFE Financing
Globenewswire· 2025-12-17 13:30
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Morien Resources Corp. (“Morien” or the “Company”) (TSX-V: MOX) is pleased to announce that it has closed its previously announced non-brokered Listed Issuer Financing Exemption offering (the “LIFE Offering”), raising gross proceeds of $1,600,000 through the issuance of 8,888,889 common shares (the “Common Shares”) of the Company at a price of $0.18 per sh ...
Survey: New Yorkers Demand Businesses Prioritize the Security and Resilience of Their Data - And are Penalizing Those that Don't
Prnewswire· 2025-12-17 13:30
New study also finds that while some New Yorkers are prioritizing their own personal security practices, gaps exist that put them and the businesses they work for at risk TINTON FALLS, N.J., Dec. 17, 2025 /PRNewswire/ -- Commvault (NASDAQ: CVLT), a leader in unified resilience at enterprise scale, today announced findings of a new Commvault-commissioned survey revealing a significant paradox in the security habits and expectations of adults in New York City, the nation's most populated metropolis. The resul ...
BlackSky's Third Gen-3 Enters Commercial Operations in Just Three Weeks Following Launch
Businesswire· 2025-12-17 13:30
HERNDON, Va.--(BUSINESS WIRE)---- $BKSY #artificialintelligence--BlackSky successfully integrates its third Gen-3 satellite into commercial operations just three weeks following launch. ...
Alaris Equity Partners Announces Closing of $115 Million Bought Deal Offering of 6.25% Convertible Unsecured Senior Debentures
Globenewswire· 2025-12-17 13:30
Core Viewpoint - Alaris Equity Partners Income Trust has successfully completed an offering of convertible unsecured senior debentures totaling $115 million, which will be used to repay existing debt and fund future investments [1][3]. Group 1: Offering Details - The offering consisted of $115 million in aggregate principal amount of debentures priced at $1,000 each, including a $15 million over-allotment option [1]. - The debentures will bear an interest rate of 6.25% per annum, with interest payments made semi-annually starting June 30, 2026 [2]. - The maturity date for the debentures is set for December 31, 2030, and they will begin trading on the Toronto Stock Exchange under the symbol "AD.DB.C" [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be utilized to partially repay outstanding indebtedness under Alaris' subsidiary's senior credit facility, which may be redrawn for future investments or general trust purposes [3]. Group 3: Company Overview - Alaris invests in a diversified group of private businesses primarily through structured equity, aiming to deliver stable and predictable returns to unitholders through cash distributions and capital appreciation [4].
Baird Medical Establishes U.S. Manufacturing Base to Accelerate Global Expansion and Future R&D
Prnewswire· 2025-12-17 13:30
The decision to anchor production in North America is driven by the Company's rapid commercial success across over a dozen countries, including recent significant market penetrations in Indonesia and Malaysia. To support this international footprint, Baird Medical has partnered with California-based MPS Medical to create a centralized production hub. This facility is designed to supply Baird Medical's advanced proprietary technologies to global markets, ensuring the highest standards of quality and supply ...
IBN Initiates Coverage of Xeriant, Inc.
Globenewswire· 2025-12-17 13:30
AUSTIN, Texas, Dec. 17, 2025 (GLOBE NEWSWIRE) -- via IBN – Xeriant, Inc. (OTCQB: XERI), a company dedicated to the discovery, development and commercialization of emergent, transformative technologies, including eco-friendly advanced materials, has engaged IBN, a multifaceted financial news and publishing company serving private and public entities, to assist with its corporate communications strategy. Xeriant operates as a strategic holding company, offering diversified exposure to next-generation aerospac ...